StemCells, Inc. Partners With R Biomedical to Develop and Commercialize Reagents for Human iPS Cell Research

[at noodls] – StemCells, Inc. Partners With R Biomedical to Develop and Commercialize Reagents for Human iPS Cell Research Announces Launch of Ultra-Primary SC Proven(R) Human Fibroblast Cell Line NEWARK, … more

View todays social media effects on STEM

View the latest stocks trending across Twitter. Click to view dashboard